Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,104,451
-
Number of holders
-
247
-
Total 13F shares, excl. options
-
92,602,268
-
Shares change
-
-1,546,648
-
Total reported value, excl. options
-
$3,277,634,496
-
Value change
-
-$49,667,719
-
Put/Call ratio
-
104%
-
Number of buys
-
121
-
Number of sells
-
-136
-
Price
-
$35.40
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2015
318 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q1 2015.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 247 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92,602,268 shares
of 93,104,451 outstanding shares and own 99% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (9,927,359 shares), Capital Research Global Investors (8,940,702 shares), Capital World Investors (8,940,000 shares), SCOPIA CAPITAL MANAGEMENT LP (5,809,799 shares), IRIDIAN ASSET MANAGEMENT LLC/CT (5,411,565 shares), VANGUARD GROUP INC (4,748,029 shares), ROYCE & ASSOCIATES LLC (3,404,200 shares), FIRST TRUST ADVISORS LP (3,326,239 shares), BlackRock Institutional Trust Company, N.A. (1,873,135 shares), and Sterling Capital Management LLC (1,677,423 shares).
This table shows the top 247 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.